Dark Forest Capital Management LP Invests $619,000 in USANA Health Sciences, Inc. (NYSE:USNA)

Dark Forest Capital Management LP acquired a new position in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 17,245 shares of the company's stock, valued at approximately $619,000. Dark Forest Capital Management LP owned approximately 0.09% of USANA Health Sciences at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Hsbc Holdings PLC purchased a new stake in shares of USANA Health Sciences during the fourth quarter worth $282,000. Dimensional Fund Advisors LP raised its holdings in USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock valued at $27,751,000 after buying an additional 55,059 shares in the last quarter. Marshall Wace LLP bought a new position in shares of USANA Health Sciences in the fourth quarter worth about $618,000. XTX Topco Ltd bought a new position in shares of USANA Health Sciences in the fourth quarter worth about $231,000. Finally, Barclays PLC increased its stake in shares of USANA Health Sciences by 12.0% in the fourth quarter. Barclays PLC now owns 31,067 shares of the company's stock worth $1,116,000 after purchasing an additional 3,330 shares during the period. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

USNA has been the topic of a number of recent analyst reports. DA Davidson dropped their price objective on USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating on the stock in a research note on Thursday, February 27th. Sidoti lowered USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, February 18th. Finally, StockNews.com lowered USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 14th.

USANA Health Sciences Trading Down 1.0 %

USNA stock traded down $0.29 during trading on Thursday, reaching $27.81. 52,552 shares of the stock were exchanged, compared to its average volume of 123,658. USANA Health Sciences, Inc. has a twelve month low of $23.10 and a twelve month high of $49.78. The company has a market capitalization of $524.40 million, a P/E ratio of 9.83, a price-to-earnings-growth ratio of 0.93 and a beta of 1.00. The stock has a 50 day simple moving average of $27.62 and a 200-day simple moving average of $33.05.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its earnings results on Tuesday, April 22nd. The company reported $0.73 earnings per share for the quarter, topping analysts' consensus estimates of $0.70 by $0.03. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The business had revenue of $249.54 million for the quarter, compared to the consensus estimate of $243.08 million. During the same period last year, the business earned $0.86 earnings per share. Equities analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insider Buying and Selling at USANA Health Sciences

In other USANA Health Sciences news, insider David Mulham Mulham sold 3,234 shares of USANA Health Sciences stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $32.98, for a total transaction of $106,657.32. Following the sale, the insider now directly owns 12,775 shares of the company's stock, valued at approximately $421,319.50. The trade was a 20.20 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Joshua Foukas sold 5,732 shares of the business's stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $32.54, for a total value of $186,519.28. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,920 shares of company stock valued at $500,285. 0.63% of the stock is currently owned by corporate insiders.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.